Combination chemotherapy of advanced ovarian cancer with cyclophosphamide (C), hexamethylmelamine (H), adriamycin (A) and diamminedichloroplatinum (D) — The “CHAD” regimen
✍ Scribed by S.E. Vogl; M. Pagano; B.H. Kaplan; A. Canalog; E. Greenwald; J. Arseneau; S. Farber
- Book ID
- 119051989
- Publisher
- Elsevier Science
- Year
- 1980
- Tongue
- English
- Weight
- 101 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Fourteen patients with advanced head and neck carcinomas received a monthly intravenous regimen of Adriamycin, 40 mg/m2, day 1; cyclophosphamide, 400 mg/m2, day 3; and cis-diamminedichloroplatinum, 20 mg/m2/1 hour, days 1-3 (CAP-3). A regression rate of only 7% (0112 squamous cell carcinomas; 112 ad
## BACKGROUND. The authors combined cisplatin and carboplatin together with cyclophosphamide to maximize platinum dose intensity in patients with advanced epithelial ovarian cancer (AOC). ## METHODS. The authors treated 26 consecutive, newly diagnosed patients with International Federation of G